SEC Form 4 · accession 0001209191-19-012298
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Vaughn
Officer — Chief Commercial Officer
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 7:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 19, 2019 | M | 938 | $31.12 | A | 25,063 | D | |
| Common StockF1 | Feb 19, 2019 | M | 257 | $27.00 | A | 25,320 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) HoldingF2 | $31.12 | Feb 19, 2019 | M | 938 | D | — | Feb 13, 2025 | Common Stock | 938 | 25,897 | D |
| Employee Stock Option (right to buy) HoldingF3 | $27.00 | Feb 19, 2019 | M | 257 | D | — | Feb 16, 2026 | Common Stock | 257 | 22,881 | D |
Explanation of responses
- F1Includes an aggregate of 19,674 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F2The option became exercisable as to 25% of the shares on February 13, 2016, and becomes exercisable as to 1/48th of the shares each full month thereafter.
- F3The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter.